We develop asset strategies and execute on activities to define the commercial opportunity, support and optimize the target product profile, understand the patient journey, and identify drivers and barriers that may shape the commercial success of clinical-stage programs.
270 engagements in the last 5 years
100+ pre-commercial assets supported in the last 5 years
250 conditions supported across 40 therapeutic areas
Where to Play
How to Win
Objective
Define key product characteristics and clinical outcomes required to be commercially viable in existing and future markets
Approach
Benchmark clinical development and outcomes thresholds for current and future potential market
Conduct research with key opinion leaders and treating specialists to validate clinical requirements and define minimal vs. optimal outcomes that would drive commercial opportunity
Conduct research with payor stakeholders to pressure-test clinical and health economic outcomes that would enable quality market access
Provide actionable recommendations to support the clinical development plan and evidence generation strategy
Objective
Understand how patents interact with the healthcare system through symptom onset, diagnosis, and management in order to identify key points that could influence activation or mitigate barriers to treatment
Approach
Conduct secondary research to establish preliminary hypotheses regarding the patient journey
Conduct claims analysis (i.e., pharmacy, medical) to evaluate patient engagement with the healthcare and a preliminary map of the patient journey
Conduct primary market research with physicians and patients test initial hypotheses, contextualize observations from the secondary research and claims analysis, characterize drivers and barriers, and highlight differences between stakeholders or segments
Refine patient journey based on stakeholder feedback and highlight key leverage points that could inform strategic priorities for product or market development